Given that the YY1 induction of miR-135b suppresses Bmal1, as shown in pancreatic cancers[68], YY1 may be important to the loss of circadian regulation of metabolism that is proposed to underpin tumour aetiology[8,20] as well as ongoing tumour pathophysiology. The gene discussed is YY1; the disease is familial pancreatic carcinoma.